Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Induced Pluripotent Stem Cells | 7 | 2022 | 160 | 2.320 |
Why?
|
| Human Embryonic Stem Cells | 9 | 2017 | 38 | 2.270 |
Why?
|
| CRISPR-Cas Systems | 9 | 2026 | 368 | 2.030 |
Why?
|
| Sulfonylurea Receptors | 3 | 2017 | 3 | 1.530 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2022 | 343 | 1.460 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 5 | 2022 | 6 | 1.360 |
Why?
|
| Hyperinsulinism | 2 | 2016 | 26 | 1.000 |
Why?
|
| Cell Differentiation | 12 | 2022 | 1386 | 0.820 |
Why?
|
| Cell Line | 13 | 2022 | 2023 | 0.800 |
Why?
|
| Myoblasts | 2 | 2022 | 64 | 0.710 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2022 | 44 | 0.690 |
Why?
|
| Cellular Reprogramming | 2 | 2019 | 41 | 0.650 |
Why?
|
| Embryoid Bodies | 5 | 2016 | 12 | 0.630 |
Why?
|
| Karyotype | 5 | 2016 | 18 | 0.630 |
Why?
|
| Insulin-Secreting Cells | 2 | 2017 | 195 | 0.580 |
Why?
|
| Heterozygote | 6 | 2017 | 173 | 0.550 |
Why?
|
| Gene Editing | 4 | 2026 | 328 | 0.520 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2016 | 242 | 0.460 |
Why?
|
| Microscopy, Fluorescence | 4 | 2016 | 401 | 0.450 |
Why?
|
| Base Sequence | 5 | 2017 | 1329 | 0.440 |
Why?
|
| Urine | 3 | 2019 | 46 | 0.400 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2026 | 22 | 0.380 |
Why?
|
| Transcription Factors | 6 | 2017 | 1554 | 0.370 |
Why?
|
| Models, Biological | 1 | 2017 | 1192 | 0.360 |
Why?
|
| Exons | 3 | 2016 | 205 | 0.350 |
Why?
|
| Embryonic Stem Cells | 2 | 2018 | 154 | 0.250 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 198 | 0.240 |
Why?
|
| Point Mutation | 2 | 2016 | 168 | 0.240 |
Why?
|
| Sequence Alignment | 2 | 2016 | 300 | 0.240 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.220 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2024 | 39 | 0.210 |
Why?
|
| Humans | 20 | 2024 | 65124 | 0.210 |
Why?
|
| Lipids | 1 | 2026 | 328 | 0.200 |
Why?
|
| Cell Lineage | 2 | 2022 | 282 | 0.190 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2022 | 1 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 43 | 0.190 |
Why?
|
| PAX3 Transcription Factor | 1 | 2022 | 12 | 0.180 |
Why?
|
| Muscle Development | 1 | 2022 | 60 | 0.170 |
Why?
|
| MicroRNAs | 2 | 2018 | 710 | 0.170 |
Why?
|
| Stem Cells | 1 | 2022 | 276 | 0.160 |
Why?
|
| Regeneration | 1 | 2022 | 125 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2026 | 784 | 0.160 |
Why?
|
| Insulin | 3 | 2022 | 695 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 277 | 0.160 |
Why?
|
| Recovery of Function | 1 | 2022 | 291 | 0.160 |
Why?
|
| Cells, Cultured | 2 | 2022 | 2188 | 0.160 |
Why?
|
| RNA, Messenger | 1 | 2026 | 1575 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2026 | 544 | 0.150 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 57 | 0.150 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2019 | 7 | 0.150 |
Why?
|
| Connectin | 1 | 2019 | 14 | 0.150 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 26 | 0.150 |
Why?
|
| Mice | 5 | 2026 | 11105 | 0.150 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2019 | 32 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 2284 | 0.140 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 88 | 0.140 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2017 | 4 | 0.140 |
Why?
|
| Argininosuccinate Lyase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Doxycycline | 1 | 2018 | 47 | 0.140 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 5 | 0.130 |
Why?
|
| Nicorandil | 1 | 2017 | 1 | 0.130 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2017 | 1 | 0.130 |
Why?
|
| Insulin Antagonists | 1 | 2017 | 3 | 0.130 |
Why?
|
| Nifedipine | 1 | 2017 | 18 | 0.130 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2017 | 3 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 1 | 2018 | 72 | 0.130 |
Why?
|
| Potassium Chloride | 1 | 2017 | 15 | 0.130 |
Why?
|
| Octreotide | 1 | 2017 | 4 | 0.130 |
Why?
|
| C-Peptide | 1 | 2017 | 24 | 0.130 |
Why?
|
| Male | 6 | 2019 | 31042 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 26 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 70 | 0.130 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 22 | 0.130 |
Why?
|
| Homozygote | 1 | 2016 | 122 | 0.120 |
Why?
|
| Phenotype | 2 | 2017 | 1232 | 0.120 |
Why?
|
| Testosterone | 1 | 2017 | 128 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 94 | 0.120 |
Why?
|
| Animals | 7 | 2026 | 21324 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 294 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 195 | 0.110 |
Why?
|
| Genotype | 1 | 2016 | 673 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 509 | 0.100 |
Why?
|
| Neurons | 1 | 2019 | 933 | 0.100 |
Why?
|
| Werner Syndrome | 1 | 2011 | 3 | 0.090 |
Why?
|
| Progeria | 1 | 2011 | 4 | 0.090 |
Why?
|
| Lamin Type A | 1 | 2011 | 13 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 40 | 0.080 |
Why?
|
| Flatfishes | 1 | 2010 | 1 | 0.080 |
Why?
|
| Fish Diseases | 1 | 2010 | 2 | 0.080 |
Why?
|
| Vibrio | 1 | 2010 | 2 | 0.080 |
Why?
|
| Vibrio Infections | 1 | 2010 | 3 | 0.080 |
Why?
|
| Mutation | 4 | 2024 | 2658 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 146 | 0.070 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 29 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4810 | 0.060 |
Why?
|
| Liposomes | 1 | 2026 | 116 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 741 | 0.050 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 2 | 0.050 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2022 | 15 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 178 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2022 | 154 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 321 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 440 | 0.040 |
Why?
|
| Middle Aged | 1 | 2016 | 18267 | 0.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 26 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 85 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2026 | 838 | 0.040 |
Why?
|
| Alleles | 1 | 2019 | 453 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 211 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 96 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 159 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 312 | 0.030 |
Why?
|
| Female | 1 | 2016 | 34016 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1589 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2022 | 3149 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 801 | 0.020 |
Why?
|
| Nuclear Lamina | 1 | 2011 | 10 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1630 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2011 | 120 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 422 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1979 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 17356 | 0.010 |
Why?
|